The Chemo-Sero-Therapeutic Research Institute
🇯🇵Japan
Clinical Trials
20
Active:0
Completed:1
Trial Phases
4 Phases
Phase 1:2
Phase 2:7
Phase 3:7
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (35.0%)Phase 3
7 (35.0%)Not Applicable
2 (10.0%)Phase 1
2 (10.0%)phase_2_3
2 (10.0%)A Study of Anti-HIV Monoclonal Antibody KD-247
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2012-11-19
- Lead Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Target Recruit Count
- 27
- Registration Number
- NCT00917813
- Locations
- 🇺🇸
Pacific Oaks Medical Group, Beverly Hills, California, United States
🇺🇸Providence Clinical Research, Burbank, California, United States
🇺🇸Peter J. Ruane, MD, Inc., Los Angeles, California, United States
News
No news found